Paper9392001
Recent advances in the treatment of malignant melanoma with gene therapy.
Hersh EM and 1 other. Mol Med, 1997. Cited by 1 paper, by iCite.
11 sourcespapers-2026-11-12-0.1.0
Cite this record
ConductScience Library. Recent advances in the treatment of malignant melanoma with gene therapy. Papers, record 9392001. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/9392001
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics6
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Genetic Therapy | Major topic |
| Melanoma | Major topic |
| Cancer Vaccines | |
| Clinical Trials as Topic | |
| Gene Transfer Techniques | |
| Humans |
Source PubMed
References100
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 9018235 | Suppression of SPARC expression by antisense RNA abrogates the tumorigenicity of human melanoma cells. | Nat Med | 1997 | https://conductscience.org/library/papers/9018235 | PubMed |
| 2 | 9072306 | Enhancement of cellular immunity in melanoma patients immunized with a peptide from MART-1/Melan A. | Cancer J Sci Am | 1997 | https://conductscience.org/library/papers/9072306 | PubMed |
| 3 | 9080123 | Intratumoral injection of GM-CSF gene encoded recombinant vaccinia virus elicits potent antitumor response in a mixture melanoma model. | Cancer Gene Ther | 1997 | https://conductscience.org/library/papers/9080123 | PubMed |
| 4 | 9113517 | The TMC Worldwide Gene Therapy Enrollment Report, end 1996. | Hum Gene Ther | 1997 | https://conductscience.org/library/papers/9113517 | PubMed |
| 5 | 9274718 | Phase I study of immunotherapy of hepatic metastases of colorectal carcinoma by direct gene transfer of an allogeneic histocompatibility antigen, HLA-B7. | Gene Ther | 1997 | https://conductscience.org/library/papers/9274718 | PubMed |
| 6 | 9815928 | Alterations in T cell receptor and signal transduction molecules in melanoma patients. | Clin Cancer Res | 1995 | https://conductscience.org/library/papers/9815928 | PubMed |
| 7 | 9816311 | Interleukin 10 production by human melanoma. | Clin Cancer Res | 1996 | https://conductscience.org/library/papers/9816311 | PubMed |
| 8 | 9816136 | Decreased expression of signal-transducing zeta chain in peripheral T cells and natural killer cells in patients with cervical cancer. | Clin Cancer Res | 1996 | https://conductscience.org/library/papers/9816136 | PubMed |
| 9 | 9815709 | Decreased antigen presentation by dendritic cells in patients with breast cancer. | Clin Cancer Res | 1997 | https://conductscience.org/library/papers/9815709 | PubMed |
| 10 | 9166458 | The development of new cancer therapies based on the molecular identification of cancer regression antigens. | Cancer J Sci Am | 1995 | https://conductscience.org/library/papers/9166458 | PubMed |
| 11 | 7524733 | Pivotal role of the B7:CD28 pathway in transplantation tolerance and tumor immunity. | Blood | 1994 | https://conductscience.org/library/papers/7524733 | PubMed |
| 12 | 7530375 | Retrovirus-mediated gene transfer in cancer therapy. | Pharmacol Ther | 1994 | https://conductscience.org/library/papers/7530375 | PubMed |
| 13 | 7833372 | Interleukin-2 gene-transduced human melanoma cells efficiently stimulate MHC-unrestricted and MHC-restricted autologous lymphocytes. | Hum Gene Ther | 1994 | https://conductscience.org/library/papers/7833372 | PubMed |
| 14 | 7844602 | Clinical application of retroviral gene transfer in oncology: results of a French study with tumor-infiltrating lymphocytes transduced with the gene of resistance to neomycin. | J Clin Oncol | 1995 | https://conductscience.org/library/papers/7844602 | PubMed |
| 15 | 7850546 | Cytokine-mediated gene therapy for cancer. | Ann Surg Oncol | 1994 | https://conductscience.org/library/papers/7850546 | PubMed |
| 16 | 7533326 | The Fas death factor. | Science | 1995 | https://conductscience.org/library/papers/7533326 | PubMed |
| 17 | 7879680 | Immunotherapy and gene therapy of cancer. | Adv Surg | 1995 | https://conductscience.org/library/papers/7879680 | PubMed |
| 18 | 7621248 | Transduction of human melanoma cells with the gamma interferon gene enhances cellular immunity. | Cancer Gene Ther | 1994 | https://conductscience.org/library/papers/7621248 | PubMed |
| 19 | 8624371 | The multidrug-resistance gene in gene therapy of cancer and hematopoietic disorders. | Ann Hematol | 1996 | https://conductscience.org/library/papers/8624371 | PubMed |
| 20 | 8785710 | Therapeutic efficacy of T cells derived from lymph nodes draining a poorly immunogenic tumor transduced to secrete granulocyte-macrophage colony-stimulating factor. | Cancer Gene Ther | 1996 | https://conductscience.org/library/papers/8785710 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Cited by
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/9392001
GET https://conductscience.org/api/papers/v1/9392001/references?page=2